Programa de reducción de riesgos de Estonia revierte su epidemia de sobredosis

Al integrar a las personas usuarias en la distribución de naloxona y programas de derivación, el pañis ha reducido significativamente sus muertes por sobredosis. Más información, en inglés, está disponible abajo.

By André Gomes / TalkingDrugs

Previously a stark example of the harms of synthetic opioids, Estonia successfully implemented a range of harm-reduction programmes that reversed its bleak opioid public health crisis.

A recent European study taking stock of the Estonian response to the rise drug-related deaths since the turn of the century demonstrates how harm reduction is an essential part of any public health programme.

Produced within the wider Synthetic Opioids prevalence, use and overdose in Europe (SO-PREP) European project, which aims to produce evidence-based recommendations to prepare for a potential synthetic opioid crisis, their Estonian report described how synthetic opioids entered the country, and how the national Health Institute responded.